PRLD — Prolight Diagnostics AB (publ) Balance Sheet
0.000.00%
- SEK277.33m
- SEK261.59m
- 10
- 15
- 73
- 20
Annual balance sheet for Prolight Diagnostics AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | — | SAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 51.1 | 43.9 | 54.1 | 13.3 | 15.7 |
Net Total Receivables | 0.231 | 0.305 | 1.44 | 9.42 | 14.3 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 51.5 | 46.3 | 56.8 | 54.1 | 30.1 |
Net Property, Plant And Equipment | — | — | 0.702 | 2.69 | 6.5 |
Net Intangible Assets | |||||
Total Assets | 154 | 149 | 208 | 169 | 166 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.18 | 2.82 | 2.51 | 36.2 | 38 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.18 | 2.82 | 2.51 | 36.2 | 38 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 153 | 146 | 205 | 133 | 128 |
Total Liabilities & Shareholders' Equity | 154 | 149 | 208 | 169 | 166 |
Total Common Shares Outstanding |